ResearcherAtrium Health Wake Forest BaptistNo recent work listed

Christopher W. Mangieri

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0633-9454; OpenAlex author ID A5043295003. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper

Papers 2

Comparison of survival for metastatic pancreatic cancer patients treated with CPI-613 versus resected borderline-resectable pancreatic cancer patients. Co-author DOI 10.1002/jso.27365 ↗
ASO Author Reflections: Aberrant Right Hepatic Artery Anatomy, an Independent Prognostic Factor for Hepatic Recurrence of Pancreatic Cancer. Co-author DOI 10.1245/s10434-022-11406-6 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Clancy J. Clark · 2 shared papers, 2022–2023 · strength 0.51
- Paper ASO Author Reflections: Aberrant Right Hepatic Artery Anatomy, an Independent Prognostic Factor for Hepatic Recurrence … DOI 10.1245/s10434-022-11406-6 ↗
- Paper Comparison of survival for metastatic pancreatic cancer patients treated with CPI-613 versus resected borderline-resect… DOI 10.1002/jso.27365 ↗
Caio M. Rocha Lima · 1 shared paper, 2023 · strength 0.18
- Paper Comparison of survival for metastatic pancreatic cancer patients treated with CPI-613 versus resected borderline-resect… DOI 10.1002/jso.27365 ↗
Perry Shen · 1 shared paper, 2023 · strength 0.18
- Paper Comparison of survival for metastatic pancreatic cancer patients treated with CPI-613 versus resected borderline-resect… DOI 10.1002/jso.27365 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.